Active Ingredient History
Piracetam is a drug marketed as a treatment for myoclonus. It is also used as a cognitive enhancer to improve memory, attention, and learning. Evidence to support its use is unclear, with some studies showing modest benefits in specific populations and others showing minimal or no benefit. Piracetam is sold as a medication in many European countries. Sale of piracetam is not illegal in the United States, although it is not regulated nor approved by the FDA so it is legally sold for research use only. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Alzheimer Disease (Phase 4)
Anxiety Disorders (Phase 3)
Cocaine-Related Disorders (Phase 1)
Dementia (Phase 3)
Dementia, Vascular (Phase 4)
Depression (Phase 3)
Postpoliomyelitis Syndrome (Phase 3)
Psychophysiologic Disorders (Phase 3)
Schizophrenia (Phase 3)
Stroke (Phase 4)
Tardive Dyskinesia (Phase 3)
Vertigo (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue